IMIPRAMINE Side Effects

6845006-8 | Anhedonia, Anxiety, Blood Follicle Stimulating Hormone Increased, Cerebral Cyst, Condition Aggravated, Dysthymic Disorder, Galactorrhoea, Sleep Disorder
on Jun 29, 2010 Female patient from INDIA , 46 years of age, was diagnosed with dysthymic disorder, type 2 diabetes mellitus and was treated with Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: anhedonia, anxiety (What is anxiety?), blood follicle stimulating hormone increased, cerebral cyst, condition aggravated, dysthymic disorder, galactorrhoea, sleep disorder (What is sleep disorder?). Imipramine dosage: 75 Mg/day. During the same period patient was treated with ESCITALOPRAM (20 Mg, Qd) (View Escitalopram Review and Escitalopram Label ).

6709111-9 | Homicidal Ideation, Irritability, Suicidal Ideation
Patient was taking Imipramine (View Usage). Patient had the following side effects: homicidal ideation, irritability, suicidal ideation on May 03, 2010 from UNITED STATES Additional patient health information: Male patient , 30 years of age, weighting 213.2 lb, was diagnosed with pollakiuria, spontaneous penile erection and. Imipramine dosage: 50 Mg Bid Po. Patient was hospitalized.

6426925-3 | Constipation
Adverse event was reported on Nov 03, 2009 by a Male patient taking Imipramine (View Usage) (Dosage: 10 Mg Bid Po) . Location: UNITED STATES , 80 years of age, weighting 123.0 lb, After Imipramine was administered, patient had the following side effects: constipation (What is constipation?). During the same period patient was treated with ACETAMINOPHEN AND HYDROCODONE BITARTRATE (5/500 Mg Prn Po) (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ).

6418602-X | Blood Pressure Decreased, Bradycardia, Depressed Level Of Consciousness, Dysarthria, Ejection Fraction Decreased, Electrocardiogram Qrs Complex Prolonged, Suicide Attempt
on Oct 28, 2009 Female patient from UNITED KINGDOM , 56 years of age, was treated with Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, bradycardia, depressed level of consciousness, dysarthria, ejection fraction decreased, electrocardiogram qrs complex prolonged, suicide attempt. Imipramine dosage: . During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.


6146269-7 | Ill-defined Disorder, Joint Stiffness, Musculoskeletal Stiffness, Oral Disorder, Product Quality Issue
on Apr 06, 2009 Female patient from UNITED STATES , 62 years of age, weighting 209.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Imipramine (View Usage). Patient had the following side effects: ill-defined disorder, joint stiffness, musculoskeletal stiffness, oral disorder, product quality issue. Imipramine dosage: 1 1 A Day. During the same period patient was treated with ABILIFY (1 1 A Day) (View Abilify Review and Abilify Label ).

6112413-0 | Hypertension
Patient was taking Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: hypertension on Mar 11, 2009 from UNITED STATES Additional patient health information: Male patient , 58 years of age, weighting 350.5 lb, was diagnosed with benign prostatic hyperplasia, urge incontinence and. Imipramine dosage: 1 Tab Bid Po.

6061897-5 | Argyria, Skin Discolouration, Skin Hyperpigmentation
Adverse event was reported on Jan 26, 2009 by a Female patient taking Imipramine (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , 64 years of age, Patient experienced the following unwanted or unexpected effects: argyria, skin discolouration, skin hyperpigmentation. During the same period patient was treated with CELECOXIB (View Celecoxib Review and Celecoxib Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), NEFAZODONE HCL (View Nefazodone Hcl Review and Nefazodone Hcl Label ), HYDROCHLOROTHIAZIDE W/IRBESARTAN (View Hydrochlorothiazide W/irbesartan Review and Hydrochlorothiazide W/irbesartan Label ).

6050017-9 | Completed Suicide
on Jan 06, 2009 Female patient from UNITED STATES , 65 years of age, was treated with Imipramine (View Usage). Patient had the following side effects: completed suicide. Imipramine dosage: Df Oral. During the same period patient was treated with RANITIDINE (Df Oral) (View Ranitidine Review and Ranitidine Label ), ACETAMINOPHEN (Df Oral) (View Acetaminophen Review and Acetaminophen Label ).

6050016-7 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
on Jan 06, 2009 Female patient from UNITED STATES , 46 years of age, was treated with Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest. Imipramine dosage: Df Oral. During the same period patient was treated with PREGABALIN (Df Oral) (View Pregabalin Review and Pregabalin Label ), SERTRALINE (Df Oral) (View Sertraline Review and Sertraline Label ), PROMETHAZINE (Df Oral) (View Promethazine Review and Promethazine Label ), CYCLOBENZAPRINE HCL (Df Oral) (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), TRAMADOL HCL (Df Oral) (View Tramadol Hcl Review and Tramadol Hcl Label ).

6050015-5 | Completed Suicide
Patient was taking Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Jan 06, 2009 from UNITED STATES Additional patient health information: Female patient , 43 years of age, . Imipramine dosage: Df Oral. During the same period patient was treated with HYDROCODONE BITARTRATE (Df Oral) (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ).

6050012-X | Cardiac Arrest, Respiratory Arrest
Adverse event was reported on Jan 06, 2009 by a Female patient taking Imipramine (View Usage) (Dosage: Df Oral) . Location: UNITED STATES , 42 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), respiratory arrest. During the same period patient was treated with OXYCODONE HCL (Df Oral) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), CYCLOBENZAPRINE HCL (Df Oral) (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), PROMETHAZINE (Df Oral) (View Promethazine Review and Promethazine Label ).

6042145-9 | Anxiety, Attention Deficit/hyperactivity Disorder, Bipolar Disorder, Condition Aggravated, Distractibility, Hallucination, Learning Disorder, Memory Impairment, Mood Swings
on Jan 09, 2009 Male patient from BRAZIL , child 8 years of age, was diagnosed with abnormal behaviour and was treated with Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: anxiety (What is anxiety?), attention deficit/hyperactivity disorder, bipolar disorder (What is bipolar disorder?), condition aggravated, distractibility, hallucination, learning disorder (What is learning disorder?), memory impairment, mood swings. Imipramine dosage: .

6039760-5 | Completed Suicide
on Jan 08, 2009 Female patient from UNITED STATES , 43 years of age, was treated with Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Imipramine dosage: Ingestion. During the same period patient was treated with HYDROCODONE BITARTRATE (Ingestion) (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ).

6022478-2 | Constipation, Dry Mouth, Panic Attack
Patient was taking Imipramine (View Usage). Patient had the following side effects: constipation (What is constipation?), dry mouth, panic attack on Dec 21, 2008 from UNITED STATES Additional patient health information: Female patient , 58 years of age, was diagnosed with panic disorder (What is panic disorder?) and. Imipramine dosage: 10 Mg. X 4 Hs Po.

5948026-0 | Aggression, Depressed Mood, Extrapyramidal Disorder, Eye Pain, Gaze Palsy, Oculogyric Crisis
Adverse event was reported on Oct 27, 2008 by a Female patient taking Imipramine (View Usage) (Dosage: (25 Mg Qd)) was diagnosed with aggression, depressed mood, bipolar disorder (What is bipolar disorder?), attention deficit/hyperactivity disorder and. Location: TURKEY , child 10 years of age, After Imipramine was administered, patient had the following side effects: aggression, depressed mood, extrapyramidal disorder, eye pain, gaze palsy, oculogyric crisis. During the same period patient was treated with VALPROIC ACID ((20 Mg/kg Qd), (10 Mg/kg Qd)) (View Valproic Acid Review and Valproic Acid Label ), METHYLPHENIDATE HCL ((10 Mg Tid), (5 Mg Tid)) (View Methylphenidate Hcl Review and Methylphenidate Hcl Label ).

5785970-1 | Abnormal Behaviour, Confusional State, Delirium, Detoxification, Disorientation, Electroencephalogram Abnormal, Partial Seizures
on Jun 13, 2008 Male patient from CHINA , 36 years of age, was treated with Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, confusional state, delirium, detoxification, disorientation, electroencephalogram abnormal, partial seizures. Imipramine dosage: Unk,unk. During the same period patient was treated with ZOPICLONE (Unk,unk) (View Zopiclone Review and Zopiclone Label ), PHENYLPROPANOLAMINE (Unk,unk) (View Phenylpropanolamine Review and Phenylpropanolamine Label ), BENZODIAZEPINES (Unk,unk) (View Benzodiazepines Review and Benzodiazepines Label ), PHENOTHIAZINE (Unk,unk) (View Phenothiazine Review and Phenothiazine Label ), OPIAT (Unk,unk) (View Opiat Review and Opiat Label ). Patient was hospitalized.

5718549-8 | Condition Aggravated, Consciousness Fluctuating, Derealisation, Electroencephalogram Abnormal, Hallucination, Auditory, Panic Attack
on Apr 18, 2008 Female patient from IRAN (ISLAMIC REPUBLIC OF) , 22 years of age, was diagnosed with panic disorder (What is panic disorder?), electroencephalogram abnormal, epilepsy (What is epilepsy?) and was treated with Imipramine (View Usage). Patient had the following side effects: condition aggravated, consciousness fluctuating, derealisation, electroencephalogram abnormal, hallucination, auditory, panic attack. Imipramine dosage: 30 Mg Daily. During the same period patient was treated with CLONAZEPAM (0.5 Mg Daily) (View Clonazepam Review and Clonazepam Label ), VALPROATE SODIUM (600 Mg Daily) (View Valproate Sodium Review and Valproate Sodium Label ), CARBAMAZEPINE (1600 Mg Daily) (View Carbamazepine Review and Carbamazepine Label ).

5508395-2 | Angle Closure Glaucoma, Anxiety Disorder, Headache, Hyperthyroidism, Intraocular Pressure Increased, Iridotomy, Mydriasis, Pupillary Reflex Impaired
Patient was taking Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: angle closure glaucoma, anxiety disorder, headache (What is headache?), hyperthyroidism, intraocular pressure increased, iridotomy, mydriasis, pupillary reflex impaired on Oct 31, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 55 years of age, was diagnosed with depression (What is depression?), hyperthyroidism and. Imipramine dosage: . During the same period patient was treated with CITALOPRAM HYDROBROMIDE (20 Mg/d) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), MIRTAZEPAM (30 Mg/d) (View Mirtazepam Review and Mirtazepam Label ), RADIOACTIVE IODINE TREATMENT (View Radioactive Iodine Treatment Review and Radioactive Iodine Treatment Label ). Patient was hospitalized.

5485815-3 | Eye Pain, Gaze Palsy, Oculogyric Crisis
Adverse event was reported on Oct 01, 2007 by a Female patient taking Imipramine (View Usage) (Dosage: 25 Mg/d) was diagnosed with depression (What is depression?), attention deficit/hyperactivity disorder, bipolar disorder (What is bipolar disorder?) and. Location: TURKEY , child 10 years of age, Patient experienced the following unwanted or unexpected effects: eye pain, gaze palsy, oculogyric crisis. During the same period patient was treated with METHYLPHENIDATE HCL (15 Mg/d) (View Methylphenidate Hcl Review and Methylphenidate Hcl Label ), VALPROIC ACID (10 Mg/kg/d) (View Valproic Acid Review and Valproic Acid Label ).

5396185-3 | Glasgow Coma Scale Abnormal, Intubation, Overdose, Therapeutic Agent Toxicity
on Jul 19, 2007 Female patient from TURKEY , 20 years of age, was diagnosed with overdose and was treated with Imipramine (View Usage). Patient had the following side effects: glasgow coma scale abnormal, intubation, overdose, therapeutic agent toxicity. Imipramine dosage: 1000 Mg. Patient was hospitalized.

5294244-7 | Pruritus
on Apr 09, 2007 Female patient from UNITED STATES , 71 years of age, weighting 272.0 lb, was treated with Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: pruritus. Imipramine dosage: .

5283988-9 | Apathy, Benign Prostatic Hyperplasia, Chills, Confusional State, Depression, Dysuria, Irritability, Suicidal Ideation
Patient was taking Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: apathy, benign prostatic hyperplasia, chills, confusional state, depression (What is depression?), dysuria, irritability, suicidal ideation on Mar 15, 2007 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 290.0 lb, was diagnosed with headache (What is headache?) and. Imipramine dosage: 10 Mg Nightly Po. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TYLENOL (View Tylenol Review and Tylenol Label ). Patient was hospitalized.

5257146-8 | Benign Prostatic Hyperplasia, Chills, Confusional State, Depression, Irritability, No Therapeutic Response, Suicidal Ideation, Suicide Attempt
Adverse event was reported on Feb 13, 2007 by a Male patient taking Imipramine (View Usage) (Dosage: 10 Mg Nightly Po) was diagnosed with headache (What is headache?) and. Location: UNITED STATES , 60 years of age, weighting 290.0 lb, Patient had the following side effects: benign prostatic hyperplasia, chills, confusional state, depression (What is depression?), irritability, no therapeutic response, suicidal ideation, suicide attempt. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TYLENOL (View Tylenol Review and Tylenol Label ). Patient was hospitalized.

5248672-6 | Hot Flush, Nausea, Night Sweats
on Feb 26, 2007 Female patient from UNITED STATES , weighting 155.0 lb, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and was treated with Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: hot flush, nausea (What is nausea?), night sweats. Imipramine dosage: Take 3 Tablets At Bedtime Po.

5224849-0 | Arteriospasm Coronary, Atrioventricular Block Complete, Blood Cholesterol Increased, Blood Uric Acid Increased, Chest Discomfort, Circulatory Collapse, Convulsion, Coronary Artery Stenosis, Electrocardiogram St Segment Depression
on Jan 18, 2007 Male patient from TAIWAN, PROVINCE OF CHINA , 59 years of age, was diagnosed with major depression and was treated with Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: arteriospasm coronary, atrioventricular block complete, blood cholesterol increased, blood uric acid increased, chest discomfort, circulatory collapse, convulsion, coronary artery stenosis, electrocardiogram st segment depression. Imipramine dosage: 112 Mg/day. During the same period patient was treated with LITHIUM CARBONATE (600 Mg/day) (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

5223424-1 | Cardio-respiratory Arrest, Completed Suicide
Patient was taking Imipramine (View Usage). Patient had the following side effects: cardio-respiratory arrest, completed suicide on Nov 30, 2006 from UNITED STATES Additional patient health information: Female patient , 27 years of age, . Imipramine dosage: Oral. During the same period patient was treated with AMITRIPTYLINE HCL (Oral) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5197269-5 | Hallucination, Labile Blood Pressure, Neuroleptic Malignant Syndrome, Rhabdomyolysis
Adverse event was reported on Dec 19, 2006 by a Male patient taking Imipramine (View Usage) (Dosage: ) was diagnosed with cancer pain and. Location: JAPAN , 57 years of age, After Imipramine was administered, patient had the following side effects: hallucination, labile blood pressure, neuroleptic malignant syndrome, rhabdomyolysis. During the same period patient was treated with PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), MORPHINE (View Morphine Review and Morphine Label ).

5163767-3 | Asthenia, Balance Disorder, Benign Neoplasm, Dizziness, Feeling Abnormal, Heart Rate Abnormal, Nervous System Disorder, Photophobia, Visual Disturbance
on Nov 27, 2006 Female patient from UNITED STATES , 23 years of age, weighting 120.0 lb, was diagnosed with depression (What is depression?) and was treated with Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, balance disorder, benign neoplasm, dizziness (What is dizziness?), feeling abnormal, heart rate abnormal, nervous system disorder, photophobia, visual disturbance. Imipramine dosage: 25-150 Mg. Per Day Daily Po.

5147488-9 | Cardio-respiratory Arrest, Completed Suicide
on Oct 30, 2006 Female patient from UNITED STATES , 27 years of age, was treated with Imipramine (View Usage). Patient had the following side effects: cardio-respiratory arrest, completed suicide. Imipramine dosage: . During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5147260-X | Cardiac Arrest, Completed Suicide, Respiratory Arrest
Patient was taking Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest on Oct 24, 2006 from UNITED STATES Additional patient health information: Female patient , 27 years of age, . Imipramine dosage: Df Po. During the same period patient was treated with AMITRIPTYLINE HCL (Df Po) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5128995-1 | Anxiety, Dyspnoea, Economic Problem, Heart Rate Increased, Memory Impairment, Pruritus, Respiratory Rate Decreased, Somnolence, Stress
Adverse event was reported on Oct 16, 2006 by a Female patient taking Imipramine (View Usage) (Dosage: 75 Mg 1x A Day Hs Po) was diagnosed with depression (What is depression?), panic disorder (What is panic disorder?) and. Location: UNITED STATES , 45 years of age, weighting 160.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dyspnoea, economic problem, heart rate increased, memory impairment, pruritus, respiratory rate decreased, somnolence, stress (What is stress?).

5030878-2 | Alanine Aminotransferase Increased, Hepatocellular Damage, Malaise
on Apr 28, 2006 Female patient from UNITED KINGDOM , 38 years of age, weighting 210.0 lb, was diagnosed with depression (What is depression?), schizophrenia and was treated with Imipramine (View Usage). Patient had the following side effects: alanine aminotransferase increased, hepatocellular damage, malaise. Imipramine dosage: 200 Mg. During the same period patient was treated with CLOZARIL (125mg) (View Clozaril Review and Clozaril Label ).

5028045-1 | Akathisia, Dystonia, Tremor
on May 29, 2006 Male patient from NETHERLANDS , 45 years of age, was diagnosed with major depression and was treated with Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: akathisia, dystonia (What is dystonia?), tremor. Imipramine dosage: 150 Mg 2x Per 1 Day.

4984528-1 | Adrenal Insufficiency, Central Venous Pressure Decreased, Hypotension
Patient was taking Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, central venous pressure decreased, hypotension on Apr 05, 2006 from JAPAN Additional patient health information: Female patient , 74 years of age, weighting 110.2 lb, was diagnosed with depression (What is depression?), anaesthesia and. Imipramine dosage: 20 Mg, Qd. During the same period patient was treated with PROPOFOL (100 Mg) (View Propofol Review and Propofol Label ), MEPIVACAINE HCL (10 Ml) (View Mepivacaine Hcl Review and Mepivacaine Hcl Label ), LOFEPRAMINE(LOFEPRAMINE) (75 Mg, Qd) (View Lofepramine(lofepramine) Review and Lofepramine(lofepramine) Label ), SEVOFLURANE (1%; 0.3%) (View Sevoflurane Review and Sevoflurane Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), VECURONIUM (VECURONIUM) (View Vecuronium (vecuronium) Review and Vecuronium (vecuronium) Label ), NITROUS OXIDE W/ OXYGEN (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ).

4957981-7 | Erythema Infectiosum, Granulocytopenia, Leukopenia, Neutropenia, Thrombocytopenia
Adverse event was reported on Mar 16, 2006 by a Female patient taking Imipramine (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , 52 years of age, Patient had the following side effects: erythema infectiosum, granulocytopenia, leukopenia, neutropenia, thrombocytopenia. During the same period patient was treated with CLOZAPINE (12.5 Mg, Unk) (View Clozapine Review and Clozapine Label ), HYDROXYCHLOROQUINE PHOSPHATE (View Hydroxychloroquine Phosphate Review and Hydroxychloroquine Phosphate Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ).

4938782-2 | Intentional Overdose
on Feb 28, 2006 Female patient from UNITED STATES , child 7 years of age, was treated with Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: intentional overdose. Imipramine dosage: Not Reported.

4938362-9 | Completed Suicide
on Feb 28, 2006 Female patient from UNITED STATES , 18 years of age, was treated with Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Imipramine dosage: Not Reported.

4938356-3 | Completed Suicide
Patient was taking Imipramine (View Usage). Patient had the following side effects: completed suicide on Feb 28, 2006 from UNITED STATES Additional patient health information: Female patient , 35 years of age, . Imipramine dosage: Not Reported. During the same period patient was treated with AMITRIPTYLINE HCL (Not Reported) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CLONAZEPAM (Not Reported) (View Clonazepam Review and Clonazepam Label ).

4938355-1 | Cardio-respiratory Arrest, Completed Suicide
Adverse event was reported on Feb 28, 2006 by a Female patient taking Imipramine (View Usage) (Dosage: Not Reported) . Location: UNITED STATES , 26 years of age, After Imipramine was administered, patient had the following side effects: cardio-respiratory arrest, completed suicide.

4938353-8 | Completed Suicide
on Feb 28, 2006 Female patient from UNITED STATES , 45 years of age, was treated with Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Imipramine dosage: Not Reported.

4938351-4 | Completed Suicide
on Feb 28, 2006 Female patient from UNITED STATES , 22 years of age, was treated with Imipramine (View Usage). Patient had the following side effects: completed suicide. Imipramine dosage: Not Reported.

4938350-2 | Completed Suicide
Patient was taking Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: completed suicide on Feb 28, 2006 from UNITED STATES Additional patient health information: Female patient , 61 years of age, . Imipramine dosage: Not Reported.

4938349-6 | Completed Suicide
Adverse event was reported on Feb 28, 2006 by a Female patient taking Imipramine (View Usage) (Dosage: Not Reported) . Location: UNITED STATES , 39 years of age, Patient experienced the following unwanted or unexpected effects: completed suicide.

4938347-2 | Cardio-respiratory Arrest, Completed Suicide
on Feb 28, 2006 Female patient from UNITED STATES , 15 years of age, was treated with Imipramine (View Usage). Patient had the following side effects: cardio-respiratory arrest, completed suicide. Imipramine dosage: Not Reported. During the same period patient was treated with PROMETHAZINE (Not Reported) (View Promethazine Review and Promethazine Label ), NAPROXEN (Not Reported) (View Naproxen Review and Naproxen Label ).

4865136-X | Asthenia, Depression, Morbid Thoughts, Surgery
on Dec 07, 2005 Female patient from UNITED STATES , 65 years of age, weighting 108.0 lb, was diagnosed with pollakiuria and was treated with Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: asthenia, depression (What is depression?), morbid thoughts, surgery (What is surgery?). Imipramine dosage: 10 Mg Nightly Po.

4861395-8 | Brain Oedema, Cardio-respiratory Arrest, Coma, Myocardial Fibrosis, Overdose, Pulmonary Congestion, Resuscitation
Patient was taking Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, cardio-respiratory arrest, coma, myocardial fibrosis, overdose, pulmonary congestion, resuscitation on Dec 06, 2005 from JAPAN Additional patient health information: Female patient , 57 years of age, weighting 123.5 lb, was diagnosed with depression (What is depression?) and. Imipramine dosage: . Patient was hospitalized.

4849664-9 | Cardio-respiratory Arrest, Coma, Overdose, Therapeutic Agent Toxicity
Adverse event was reported on Nov 22, 2005 by a Female patient taking Imipramine (View Usage) (Dosage: Df Po) . Location: JAPAN , 57 years of age, weighting 123.5 lb, Patient had the following side effects: cardio-respiratory arrest, coma, overdose, therapeutic agent toxicity. Patient was hospitalized.

4847507-0 | Apnoeic Attack, Circulatory Failure Neonatal, Pallor
on Nov 24, 2005 Male patient from JAPAN , weighting 2.23 lb, was treated with Imipramine (View Usage). After Imipramine was administered, patient had the following side effects: apnoeic attack, circulatory failure neonatal, pallor. Imipramine dosage: . During the same period patient was treated with ETIZOLAM (View Etizolam Review and Etizolam Label ).

4838054-0 | Loss Of Consciousness, Torsade De Pointes
on Nov 23, 2005 Female patient from UNITED STATES , 45 years of age, was treated with Imipramine (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, torsade de pointes. Imipramine dosage: 25mg - 50 Mg. During the same period patient was treated with NORETHINDRONE (View Norethindrone Review and Norethindrone Label ).

4816579-1 | Morbid Thoughts
Patient was taking Imipramine (View Usage). Patient had the following side effects: morbid thoughts on Oct 11, 2005 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 108.0 lb, was diagnosed with pollakiuria and. Imipramine dosage: 10 Mg Nightly Po.